id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0092-0010,FDA,FDA-2008-E-0092,Determination of Regulatory Review Period for Purposes of Patent Extensions: XYZAL,Notice,General Notice,2011-06-24T04:00:00Z,2011,6,2011-06-24T04:00:00Z,,2011-06-24T18:41:42Z,2011-15910,0,0,0900006480eb33fd
FDA-2008-E-0092-0009,FDA,FDA-2008-E-0092,FDA\CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2011-06-03T04:00:00Z,2011,6,2011-06-03T04:00:00Z,,2011-06-03T16:27:45Z,,0,0,0900006480e3a989